BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 10891349)

  • 1. In situ photoaffinity labeling of proteasome with photoactive adriamycin analogue.
    Kiyomiya KI; Matsuo S; Kurebe M
    Biochem Biophys Res Commun; 2000 Jul; 273(3):928-32. PubMed ID: 10891349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of specific nuclear transport of adriamycin: the mode of nuclear translocation of adriamycin-proteasome complex.
    Kiyomiya K; Matsuo S; Kurebe M
    Cancer Res; 2001 Mar; 61(6):2467-71. PubMed ID: 11289116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between nuclear action of anthracycline anticancer agents and their binding affinity to the proteasome.
    Kiyomiya K; Satoh J; Horie H; Kurebe M; Nakagawa H; Matsuo S
    Int J Oncol; 2002 Nov; 21(5):1081-5. PubMed ID: 12370758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purification of the multicatalytic proteinase from the nucleus and cytoplasm of chicken red blood cells.
    Strack PR; Wajnberg EF; Waxman L; Fagan JM
    Biomed Biochim Acta; 1991; 50(4-6):479-81. PubMed ID: 1801712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of the proteasome in apoptosis induced by anthracycline anticancer agents.
    Kiyomiya K; Kurebe M; Nakagawa H; Matsuo S
    Int J Oncol; 2002 Jun; 20(6):1205-9. PubMed ID: 12012000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemistry in living cells: detection of active proteasomes by a two-step labeling strategy.
    Ovaa H; van Swieten PF; Kessler BM; Leeuwenburgh MA; Fiebiger E; van den Nieuwendijk AM; Galardy PJ; van der Marel GA; Ploegh HL; Overkleeft HS
    Angew Chem Int Ed Engl; 2003 Aug; 42(31):3626-9. PubMed ID: 12916032
    [No Abstract]   [Full Text] [Related]  

  • 7. Proteasome is a carrier to translocate doxorubicin from cytoplasm into nucleus.
    Kiyomiya K; Matsuo S; Kurebe M
    Life Sci; 1998; 62(20):1853-60. PubMed ID: 9600327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactacystin, a proteasome inhibitor, potentiates the apoptotic effect of parthenolide, an inhibitor of NFkappaB activation, on drug-resistant mouse leukemia L1210 cells.
    Cory AH; Cory JG
    Anticancer Res; 2002; 22(6C):3805-9. PubMed ID: 12552998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation and subunit composition of the 20S proteasome of Giardia lamblia.
    Emmerlich V; Santarius U; Bakker-Grunwald T; Scholze H
    Mol Biochem Parasitol; 1999 May; 100(1):131-4. PubMed ID: 10377001
    [No Abstract]   [Full Text] [Related]  

  • 10. Properties of the nuclear proteasome activator PA28gamma (REGgamma).
    Wilk S; Chen WE; Magnusson RP
    Arch Biochem Biophys; 2000 Nov; 383(2):265-71. PubMed ID: 11185562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of heat shock on 20S/26S proteasomes.
    Kuckelkorn U; Knuehl C; Boes-Fabian B; Drung I; Kloetzel PM
    Biol Chem; 2000; 381(9-10):1017-23. PubMed ID: 11076035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of the ubiquitin-proteasome pathway with a cytosolic oligopeptidase activity.
    Wang EW; Kessler BM; Borodovsky A; Cravatt BF; Bogyo M; Ploegh HL; Glas R
    Proc Natl Acad Sci U S A; 2000 Aug; 97(18):9990-5. PubMed ID: 10954757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-dependent declines in proteasome activity in the heart.
    Bulteau AL; Szweda LI; Friguet B
    Arch Biochem Biophys; 2002 Jan; 397(2):298-304. PubMed ID: 11795886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Entry into a new class of potent proteasome inhibitors having high antiproliferative activity by structure-based design.
    Furet P; Imbach P; Noorani M; Koeppler J; Laumen K; Lang M; Guagnano V; Fuerst P; Roesel J; Zimmermann J; García-Echeverría C
    J Med Chem; 2004 Sep; 47(20):4810-3. PubMed ID: 15369383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reconstitution of hybrid proteasomes from purified PA700-20 S complexes and PA28alphabeta activator: ultrastructure and peptidase activities.
    Kopp F; Dahlmann B; Kuehn L
    J Mol Biol; 2001 Oct; 313(3):465-71. PubMed ID: 11676531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant ATPases of the yeast 26S proteasome activate protein degradation by the 20S proteasome.
    Takeuchi J; Tamura T
    FEBS Lett; 2004 May; 565(1-3):39-42. PubMed ID: 15135049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opening doors into the proteasome.
    Pickart CM; VanDemark AP
    Nat Struct Biol; 2000 Nov; 7(11):999-1001. PubMed ID: 11062549
    [No Abstract]   [Full Text] [Related]  

  • 18. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors.
    Demasi M; Shringarpure R; Davies KJ
    Arch Biochem Biophys; 2001 May; 389(2):254-63. PubMed ID: 11339815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct 19 S and 20 S subcomplexes of the 26 S proteasome and their distribution in the nucleus and the cytoplasm.
    Peters JM; Franke WW; Kleinschmidt JA
    J Biol Chem; 1994 Mar; 269(10):7709-18. PubMed ID: 8125997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigen processing by the proteasome.
    Kloetzel PM
    Nat Rev Mol Cell Biol; 2001 Mar; 2(3):179-87. PubMed ID: 11265247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.